Molecular analysis of isoniazid resistance in Mycobacterium tuberculosis isolates recovered from South Korea.
The katG, inhA and ahpC genes, in 71 isoniazid (INH)-resistant and 26 INH-susceptible Mycobacterium tuberculosis isolates, from South Korea were examined by sequencing and MspI restriction enzyme analysis. Mutations in the katG 315 alone, katG 315 plus inhA, katG 315 plus ahpC, katG 309 alone, katG 309 plus inhA, inhA alone, and ahpC alone, were detected in 54.9, 2.8, 1.4, 1.4, 1.4, 19.7, and 5.6% of the 71 INH-resistant isolates, respectively. There was no statistically significant difference (p > 0.05) in the frequencies of these mutations for the INH-monoresistant compared with the multidrug-resistant isolates. Mutations in the katG codon 315 were associated with the high-level of INH resistance (MIC, >1 microg/ml), whereas the mutation in the inhA promoter region was associated with the low-level of INH resistance (MIC, >0.2 to 1 microg/ml). The previously undescribed GGT-->GAT (Gly-->Asp) mutation in the katG codon 309 was found in two rifampin, including-multidrug-resistant isolates, but we cannot assess if this is predictive of INH resistance. The sensitivity and specificity of molecular analysis of the katG codon 315 and/or the inhA promoter region were 80.3 and 100%, respectively. Therefore, mutations in these regions are highly predictive of INH resistance in South Korea.
Kim
Soo-Young
SY
Department of Clinical Pathology, College of Medicine, the Catholic University of Korea, St. Vincent's Hospital, 93 Chi-dong, 442-723, Paldal-ku, Suwon, South Korea.
Park
Yeon-Joon
YJ
Kim
Won-Il
WI
Lee
Sun-Hwa
SH
Ludgerus Chang
Chulhun
C
Kang
Seok-Jin
SJ
Kang
Chang-Suk
CS
D001426:Bacterial Proteins; D016009:Chi-Square Distribution; D004252:DNA Mutational Analysis; D024881:Drug Resistance, Bacterial; D005260:Female; D005798:Genes, Bacterial / Q000235:genetics*; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology*; D007723:Korea; D008297:Male; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000235:genetics*; D010088:Oxidoreductases / Q000235:genetics*; D010544:Peroxidases / Q000235:genetics; D016133:Polymerase Chain Reaction / Q000379:methods; D012150:Polymorphism, Restriction Fragment Length; D011336:Probability; D011401:Promoter Regions, Genetic; D012680:Sensitivity and Specificity; D018088:Tuberculosis, Multidrug-Resistant / Q000235:genetics*
D001426:Bacterial Proteins; D010088:Oxidoreductases; D010544:Peroxidases; C076136:catalase HPI; C085257:InhA protein, Mycobacterium; D007538:Isoniazid